article thumbnail

Mental Health’s Unfinished Digital Revolution

The Healthcare Blog

The Current Market and Roadmaps Rock Health Capital appeared optimistic about 2024. Dr. Trevor van Mierlo has built mental health and patient support products for more than two decades and is the CEO of Evolution Health What other industries have addressed opportunities with high TAM, SAM, and SOM? Is there a roadmap?

article thumbnail

What Stays True for U.S. Health Care Post #Election2024 (1) – Consumers’ Dissatisfaction with Drug Prices

Health Populi

For health care, there are many uncertainties as we reflect, one week after the 2024 U.S. Pollfish conducted this study online in October 2024. elections, on probably policy and market impacts that we can expect in 2025 and beyond. health citizens and key factors shaping the American health ecosystem. than anywhere else in the world.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Software Living in an Enterprise World: Why Digital Behavioral Health Can’t Gain Traction

The Healthcare Blog

No More Excuses Fast forward to 2024. Dr. Trevor van Mierlo has built mental health and patient support products for more than two decades and is the CEO of Evolution Health According to a recent article in Forbes , there are 5.4 billion internet users worldwide (66% of the global population). In the U.S.,

Insurance 120
article thumbnail

Mastering Prior Authorization Roles: Responsibilities and Training Demands Explored

ACMA Blog

Patient Support Services: These teams within pharmaceutical manufacturers provide dedicated resources to help patients access and afford the prescribed medications. This includes operating patient assistance programs that offer copay assistance, free drug supplies, and connections to independent charitable foundations.

article thumbnail

Primary care news round-up (14th to 20th March 2024)

Practice Index

Practices urged to win patient support for funding As an election looms, practices are being encouraged to win patient support for more investment in primary care. The post Primary care news round-up (14th to 20th March 2024) appeared first on GP Practice Management Blog.

article thumbnail

Amber Specialty Pharmacy Selected To Dispense NEMLUVIO® (nemolizumab-ilto) by Galderma for Prurigo Nodularis

Amber Pharmacy

12, 2024) – Amber Specialty Pharmacy, a leader in the specialty pharmacy industry, is excited to announce the availability of Galderma’s latest medication, NEMLUVIO® (nemolizumab-ilto), for the treatment of Prurigo Nodularis in adults. Omaha, Neb.